These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16713573)
21. Deregulation of cyclin E meets dysfunction in p53: closing the escape hatch on breast cancer. Barton MC; Akli S; Keyomarsi K J Cell Physiol; 2006 Dec; 209(3):686-94. PubMed ID: 17001684 [TBL] [Abstract][Full Text] [Related]
22. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559 [TBL] [Abstract][Full Text] [Related]
23. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Eymin B; Gazzeri S; Brambilla C; Brambilla E Oncogene; 2002 Apr; 21(17):2750-61. PubMed ID: 11965548 [TBL] [Abstract][Full Text] [Related]
24. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status. Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024 [TBL] [Abstract][Full Text] [Related]
25. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594 [TBL] [Abstract][Full Text] [Related]
27. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation. Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-Séguin N Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538 [TBL] [Abstract][Full Text] [Related]
28. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458 [TBL] [Abstract][Full Text] [Related]
29. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation. Wang L; Liu R; Ye P; Wong C; Chen GY; Zhou P; Sakabe K; Zheng X; Wu W; Zhang P; Jiang T; Bassetti MF; Jube S; Sun Y; Zhang Y; Zheng P; Liu Y Nat Commun; 2015 Jan; 6():5909. PubMed ID: 25600590 [TBL] [Abstract][Full Text] [Related]
30. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Chen D; Kon N; Li M; Zhang W; Qin J; Gu W Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956 [TBL] [Abstract][Full Text] [Related]
31. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis. Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957 [TBL] [Abstract][Full Text] [Related]
32. Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis. Van Maerken T; Vandesompele J; Rihani A; De Paepe A; Speleman F Cell Death Differ; 2009 Dec; 16(12):1563-72. PubMed ID: 19779493 [TBL] [Abstract][Full Text] [Related]
33. Dual Role of the Alternative Reading Frame ARF Protein in Cancer. Fontana R; Ranieri M; La Mantia G; Vivo M Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30836703 [TBL] [Abstract][Full Text] [Related]
34. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children. Wilda M; Bruch J; Harder L; Rawer D; Reiter A; Borkhardt A; Woessmann W Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292 [TBL] [Abstract][Full Text] [Related]
35. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma]. Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849 [TBL] [Abstract][Full Text] [Related]
36. The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression. Suzuki H; Kurita M; Mizumoto K; Moriyama M; Aiso S; Nishimoto I; Matsuoka M Biochem Biophys Res Commun; 2005 Jan; 326(1):242-8. PubMed ID: 15567177 [TBL] [Abstract][Full Text] [Related]
37. The ARF tumour suppressor. Gallagher SJ; Kefford RF; Rizos H Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663 [TBL] [Abstract][Full Text] [Related]
38. Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation. Vivo M; Ranieri M; Sansone F; Santoriello C; Calogero RA; Calabrò V; Pollice A; La Mantia G PLoS One; 2013; 8(1):e53631. PubMed ID: 23308265 [TBL] [Abstract][Full Text] [Related]
39. p53 and ARF: unexpected players in autophagy. Balaburski GM; Hontz RD; Murphy ME Trends Cell Biol; 2010 Jun; 20(6):363-9. PubMed ID: 20303758 [TBL] [Abstract][Full Text] [Related]
40. ARF promotes accumulation of retinoblastoma protein through inhibition of MDM2. Chang DL; Qiu W; Ying H; Zhang Y; Chen CY; Xiao ZX Oncogene; 2007 Jul; 26(32):4627-34. PubMed ID: 17297463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]